According to a new report, published by KBV research, The Global Antimicrobial Suture Market size is expected to reach $367.5 million by 2031, rising at a market growth of 3.5% CAGR during the forecast period.
The Absorbable segment is leading the Global Antimicrobial Suture Market by Type in 2023; thereby, achieving a market value of $238.3 million by 2031. Absorbable sutures eliminate the need for a secondary procedure to remove sutures, which is particularly advantageous in reducing patient discomfort and healthcare costs. This is especially beneficial in surgeries where sutures are placed in internal or inaccessible areas. Patients and healthcare providers benefit from simplified postoperative care, as absorbable sutures naturally degrade over time, reducing the need for follow-up visits and suture removal procedures.
The Clinics segment is anticipating a CAGR of 4.2% during (2024 - 2031). Clinics are increasingly performing minor surgical procedures that were traditionally conducted in hospitals. These procedures, such as dermatological surgeries, minor orthopedic repairs, and elective surgeries, require effective infection control measures, including antimicrobial sutures. The increased patient volume in clinics has led to more frequent minor surgeries and wound closures.
Full Report: https://www.kbvresearch.com/antimicrobial-suture-market/
The North America region dominated the Global Antimicrobial Suture Market by Region in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $133.8 million by 2031. The Europe region is experiencing a CAGR of 3.1% during (2024 - 2031). Additionally, The Asia Pacific region would exhibit a CAGR of 4.1% during (2024 - 2031).
By Type
By End User
By Geography
Unique Offerings 
